Literature DB >> 27472205

Congenital cataract associated with persistent fetal vasculature: findings from IoLunder2.

A L Solebo1,2,3,4, I Russell-Eggitt2,4, P Cumberland1,4, J S Rahi1,2,3,4.   

Abstract

PurposeTo describe the frequency, characteristics, and treatment outcome of persistent fetal vasculature (PFV) in children undergoing surgery for congenital and infantile cataract in the first 2 years of life.Patients and methodsObservational population-based cohort study with case identification through active surveillance and standardised data collection via a national clinical network, the British Isles Congenital Cataract Interest Group (BCCIG).ResultsThe IoLunder2 cohort comprises 246 children undergoing surgery for bilateral and unilateral congenital and infantile cataract in the first 2 years of life. A total of 58/246 (24%) children had PFV (%): overall, 46/95 (46%) with unilateral cataract, and 12/141 (8%) with bilateral disease. Anterior segment vascular remnants were more common in bilateral than unilateral disease (75 vs 11%, P=0.01). At 1 year after surgery, 20% of children with bilateral PFV and 24% with unilateral had achieved normal vision for age within the operated eye. The prevalence of post-operative glaucoma was 9% (of children with bilateral disease) and 4% (unilateral).ConclusionPFV is significantly more common than previously reported, and outcomes are comparable to that for congenital and infantile cataract overall.

Entities:  

Mesh:

Year:  2016        PMID: 27472205      PMCID: PMC5023809          DOI: 10.1038/eye.2016.159

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  16 in total

1.  Persistent hyperplastic primary vitreous.

Authors:  A B REESE
Journal:  Am J Ophthalmol       Date:  1955-09       Impact factor: 5.258

2.  Pediatric cataract: the Toronto experience-etiology.

Authors:  Zena Lim; Shehla Rubab; Yiong Huak Chan; Alex V Levin
Journal:  Am J Ophthalmol       Date:  2010-04-28       Impact factor: 5.258

3.  Personalized diagnosis and management of congenital cataract by next-generation sequencing.

Authors:  Rachel L Gillespie; James O'Sullivan; Jane Ashworth; Sanjeev Bhaskar; Simon Williams; Susmito Biswas; Elias Kehdi; Simon C Ramsden; Jill Clayton-Smith; Graeme C Black; I Christopher Lloyd
Journal:  Ophthalmology       Date:  2014-08-19       Impact factor: 12.079

4.  Comparison of contact lens and intraocular lens correction of monocular aphakia during infancy: a randomized clinical trial of HOTV optotype acuity at age 4.5 years and clinical findings at age 5 years.

Authors:  Scott R Lambert; Michael J Lynn; E Eugenie Hartmann; Lindreth DuBois; Carolyn Drews-Botsch; Sharon F Freedman; David A Plager; Edward G Buckley; M Edward Wilson
Journal:  JAMA Ophthalmol       Date:  2014-06       Impact factor: 7.389

5.  Infant Aphakia Treatment Study: effects of persistent fetal vasculature on outcome at 1 year of age.

Authors:  David G Morrison; M Edward Wilson; Rupal H Trivedi; Scott R Lambert; Michael J Lynn
Journal:  J AAPOS       Date:  2011-10       Impact factor: 1.220

6.  Visual and anatomic outcomes with or without surgery in persistent fetal vasculature.

Authors:  Robert A Sisk; Audina M Berrocal; William J Feuer; Timothy G Murray
Journal:  Ophthalmology       Date:  2010-11       Impact factor: 12.079

7.  Congenital fibrovascular pupillary membranes: clinical and histopathologic findings.

Authors:  Scott R Lambert; Edward G Buckley; Phoebe D Lenhart; Qing Zhang; Hans E Grossniklaus
Journal:  Ophthalmology       Date:  2011-12-22       Impact factor: 12.079

8.  Congenital and infantile cataract in the United Kingdom: underlying or associated factors. British Congenital Cataract Interest Group.

Authors:  J S Rahi; C Dezateux
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-07       Impact factor: 4.799

9.  VEGF and KDR gene expression during human embryonic and fetal eye development.

Authors:  Karïn Gogat; Laurence Le Gat; Loïc Van Den Berghe; Dominique Marchant; Alexandra Kobetz; Stéphanie Gadin; Bernard Gasser; Isabelle Quéré; Marc Abitbol; Maurice Menasche
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-01       Impact factor: 4.799

10.  Risks and outcomes associated with primary intraocular lens implantation in children under 2 years of age: the IoLunder2 cohort study.

Authors:  Ameenat Lola Solebo; Isabelle Russell-Eggitt; Phillippa M Cumberland; Jugnoo S Rahi
Journal:  Br J Ophthalmol       Date:  2015-05-06       Impact factor: 4.638

View more
  6 in total

1.  Ocular development in children with unilateral congenital cataract and persistent fetal vasculature.

Authors:  Shu-Yi Zhang; Hui Chen; Jing-Hui Wang; Wan Chen; Qi-Wei Wang; Jing-Jing Chen; Xiao-Shan Lin; Zhuo-Ling Lin; Duo-Ru Lin; Hao-Tian Lin; Wei-Rong Chen
Journal:  Int J Ophthalmol       Date:  2022-03-18       Impact factor: 1.779

2.  Cataract morphology and risk for glaucoma after cataract surgery in infants with unilateral congenital cataract.

Authors:  Elias I Traboulsi; Sharon F Freedman; M Edward Wilson; Scott R Lambert
Journal:  J Cataract Refract Surg       Date:  2017-12       Impact factor: 3.351

Review 3.  Innovations in pediatric cataract surgery.

Authors:  Sudarshan Kumar Khokhar; Ganesh Pillay; Esha Agarwal; Manish Mahabir
Journal:  Indian J Ophthalmol       Date:  2017-03       Impact factor: 1.848

4.  Practice patterns in pediatric cataract management: Time for real world data.

Authors:  Ken Kanwal Nischal
Journal:  Indian J Ophthalmol       Date:  2017-09       Impact factor: 1.848

5.  Evaluation of collagen derived antiangiogenic factors and matrix metalloproteinases in anterior lens epithelial cells of pediatric eyes with persistent fetal vasculature.

Authors:  Devarshi U Gajjar; Abhay R Vasavada; Priyanka Patel; Mamidipudi R Praveen; Sajani R Shah
Journal:  Indian J Ophthalmol       Date:  2019-10       Impact factor: 1.848

Review 6.  Cataract management in children: a review of the literature and current practice across five large UK centres.

Authors:  J E Self; R Taylor; A L Solebo; S Biswas; M Parulekar; A Dev Borman; J Ashworth; R McClenaghan; J Abbott; E O'Flynn; D Hildebrand; I C Lloyd
Journal:  Eye (Lond)       Date:  2020-08-10       Impact factor: 3.775

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.